PR Newswire Consumer
prCenter
CAPR Investor Alert: Capricor Therapeutics, Inc. Securities Class Action Notice - Contact SueWallSttranslating…
Capricor Therapeutics shareholders who purchased between December 17, 2025 and July 26, 2026 retain specific rights under federal securities law, including the ability to seek recovery of losses tied to an alleged $15.08 per-share decline following FDA briefing documents on the…
Keywords#Capricor Therapeutics#Securities#Action#Action Notice#Alert
Comments
Sign in to join the discussion.
Loading comments…